Can we assess the risk of embolic complications of cardioversion?
Pol Arch Med Wewn
.
2016;126(1-2):5-6.
doi: 10.20452/pamw.3251.
Authors
Andrzej Gackowski
,
Maciej Stąpór
PMID:
26842373
DOI:
10.20452/pamw.3251
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / therapeutic use
Atrial Fibrillation
Electric Countershock*
Embolism*
Humans
Thromboembolism / drug therapy
Substances
Anticoagulants